Citigroup’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $579K | Sell |
|
|||||
|
2025
Q2 | $2.02M | Sell |
|
|||||
|
2025
Q1 | $2.37M | Buy |
|
|||||
|
2024
Q4 | $3.02M | Buy |
|
|||||
|
2024
Q3 | $1.72M | Buy |
|
|||||
|
2024
Q2 | $935K | Sell |
|
|||||
|
2024
Q1 | $7.6M | Buy |
|
|||||
|
2023
Q4 | $2.47M | Sell |
|
|||||
|
2023
Q3 | $1.91M | Sell |
|
|||||
|
2023
Q2 | $2.4M | Sell |
|
|||||
|
2023
Q1 | $4.24M | Buy |
|
|||||
|
2022
Q4 | $2.83M | Sell |
|
|||||
|
2022
Q3 | $5.32M | Buy |
|
|||||
|
2022
Q2 | $4.2M | Buy |
|
|||||
|
2022
Q1 | $2.16M | Sell |
|
|||||
|
2021
Q4 | $4.6M | Buy |
|
|||||
|
2021
Q3 | $5.9M | Sell |
|
|||||
|
2021
Q2 | $4.02M | Sell |
|
|||||
|
2021
Q1 | $3.57M | Buy |
|
|||||
|
2020
Q4 | $624K | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $6K | Sell |
|
|||||
|
2018
Q3 | $23K | Sell |
|
|||||
|
2018
Q2 | $121K | Buy |
|
|||||
|
2018
Q1 | $183K | Buy |
|
|||||
|
2017
Q4 | $83K | Buy |
|
|||||
|
2017
Q3 | $55K | Buy |
|
|||||
|
2017
Q2 | $44K | Sell |
|
|||||
|
2017
Q1 | $422K | Sell |
|
|||||
|
2016
Q4 | $1.5M | Buy |
|
|||||
|
2016
Q3 | $246K | Buy |
|
|||||
|
2016
Q2 | $206K | Sell |
|
|||||
|
2016
Q1 | $363K | Buy |
|
|||||
|
2015
Q4 | $428K | Sell |
|
|||||
|
2015
Q3 | $522K | Buy |
|
|||||
|
2015
Q2 | $552K | Sell |
|
|||||
|
2015
Q1 | $775K | Sell |
|
|||||
|
2014
Q4 | $741K | Buy |
|
|||||
|
2014
Q3 | $114K | Sell |
|
|||||
|
2014
Q2 | $163K | Sell |
|
|||||
|
2014
Q1 | $834K | Sell |
|
|||||
|
2013
Q4 | $1.79M | Buy |
|
|||||
|
2013
Q3 | $1.25M | Buy |
|
|||||
|
2013
Q2 | $46K | Buy |
|